RMCP / Revolutions Medical Corp. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Other Events

rmcp201504068k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 3, 2015 REVOLUTIONS MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Nevada 000-28629 73-1526138 (State or other jurisdiction of inc

Revolutions Medical FORM NT 10-K

rmcp20150331nt10k.htm UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Washington, D.C. 20549 Expires: August 31, 2015 Estimated average burden hours per response?????????... 2.50 FORM 12b-25 SEC FILE NUMBER NOTIFICATION OF LATE FILING 000-28629 CUSIP NUMBER (Check one): ?Form 10-K ? Form 20-F ? Form 11-K ?Form 10-Q? Form 10-D ? Form N-SAR ? Form N-CSR For Period

RMCP / Revolutions Medical Corp. S-1/A - - FORM S-1/A

S-1/A 1 rmcp20141117s1a.htm FORM S-1/A Registration No. 333-198767 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A (Amendment No. 1) REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 REVOLUTIONS MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Nevada 3841 73-1526138 (State or other jurisdiction of incorporation) (Primary Standard I

EX-10

ex10-22.htm Exhibit 10.22

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

8-K 1 rmcp201501058k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 12, 2014 REVOLUTIONS MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Nevada 000-28629 73-1526138 (State or other

EX-3

ex3-1.htm Exhibit 3.1

RMCP / Revolutions Medical Corp. DEF 14C - - FORM DEF 14C

rmcp20141201pre14c.htm SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14 (c) of the Securities Exchange Act of 1934 (Amendment No. ) Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5 (d)(2)) ☒ Definitive Information Statement REVOLUTIONS MEDICAL CORPORATION (Name of Registrant as Specified i

RMCP / Revolutions Medical Corp. PRE 14C - - FORM PRE 14C

rmcp20141201pre14c.htm SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14 (c) of the Securities Exchange Act of 1934 (Amendment No. ) Check the appropriate box: ☒ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5 (d)(2)) ☐ Definitive Information Statement REVOLUTIONS MEDICAL CORPORATION (Name of Registrant as Specified i

Other Events

rmcp201411198k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2014 REVOLUTIONS MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Nevada 000-28629 73-1526138 (State or other jurisdiction of

Revolutions Medical FORM 10-Q (Quarterly Report)

rmcp2014093010q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended: September 30, 2014 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 000-28629 REVO

RMCP / Revolutions Medical Corp. S-1 - Registration Statement - FORM S-1

Registration No. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 REVOLUTIONS MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Nevada 3841 73-1526138 (State or other jurisdiction of incorporation) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification

EX-10

ex10-22.htm Exhibit 10.22

Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits

rmcp201409058k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 15, 2014 REVOLUTIONS MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Nevada 000-28629 73-1526138 (State or other jurisdiction o

REGISTRATION RIGHTS AGREEMENT

ex10-2.htm Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (the “Agreement”), dated as of September 15, 2014 (the “Execution Date”), is entered into by and Revolutions Medical Corporation, a Nevada corporation with its principal executive office at 1124 Park West Blvd. Suite #102, Mount Pleasant, SC 29466 (the “Company”), and KVM Capital Partners, a New York company (

RMCP / Revolutions Medical Corp. RW - - FORM RW

rmcp20140905rw.htm Revolutions Medical Corporation 1124 Park West Boulevard Suite 102 Mount Pleasant, SC 29466 September 15, 2014 VIA EDGAR Amanda Ravitz, Assistant Director Division of Corporation Finance Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 Re: Revolutions Medical Corporation Amendment No. 1 to Registration Statement on Form S-1 Filed June 17, 2014 File No.

TERMINATION AGREEMENT

ex10-3.htm Exhibit 10.3 TERMINATION AGREEMENT This Termination Agreement (the “Agreement”), dated as of September 15, 2014, by and between Revolutions Medical Corporation, a Nevada corporation, (the “Company”), and KVM Capital Partners, a New York limited liability company (the “Investor”). WHEREAS: A. The Company and the Investor are parties to an Investment Agreement dated as of June 10, 2013 (t

INVESTMENT AGREEMENT

ex10-1.htm Exhibit 10.1 INVESTMENT AGREEMENT This INVESTMENT AGREEMENT (the “Agreement”), dated as of September 15, 2014 (the “Execution Date”), is entered into by and between Revolutions Medical Corporation a Nevada corporation with its principal executive office at 1124 Park West Blvd. Suite #102, Mount Pleasant, SC 29466 (the “Company”), and KVM Capital Partners, a New York company (the “Invest

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

rmcp2014063010q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended: June 30, 2014 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 000-28629 REVOLUTIO

RMCP / Revolutions Medical Corp. NT 10-Q - - FORM NT 10-Q

rmcp20140814nt10q.htm UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response………………………... 2.50 FORM 12b-25 SEC FILE NUMBER NOTIFICATION OF LATE FILING 000-28629 CUSIP NUMBER (Check one): ☐Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Peri

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

8-K 1 rmcp201408068k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 24, 2014 REVOLUTIONS MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Nevada 000-28629 73-1526138 (State or other juri

- FORM S-1/A

Registration No. 333-195393 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A1 AMENDMENT NO. 1 TO REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 REVOLUTIONS MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Nevada 3841 73-1526138 (State or other jurisdiction of incorporation) (Primary Standard Industrial Classification Code Number)

UNITED STATES

rmcp2014033110q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended: March 31, 2014 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 000-28629 REVOLUTI

RMCP / Revolutions Medical Corp. / Carebourn Capital, L.P. - SCHEDULE 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13D Under the Securities Exchange Act of 1934 REVOLUTIONS MEDICAL CORPORATION (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 76154Q106 (CUSIP Number) Carebourn Capital, LP c/o Chip Rice, Managing Member 8700 Blackoaks Lane North Maple Grove, MN 55311 (612) 889-4671 (Name, Address and Te

- FORM NT 10-Q

rmcp20140515nt10q.htm OMB APPROVAL UNITED STATES OMB Number: 3235-0058 SECURITIES AND EXCHANGE COMMISSION Expires: August 31, 2015 Washington, D.C. 20549 Estimated average burden hours per response………………………... 2.50 FORM 12b-25 SEC FILE NUMBER NOTIFICATION OF LATE FILING 000-28629 CUSIP NUMBER (Check one): ☐Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Perio

Other Events - FORM 8-K

rmcp20140508b8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2014 REVOLUTIONS MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Nevada 000-28629 73-1526138 (State or other jurisdiction of inco

Registration Statement - FORM S-1

rmcp20140326s1.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 REVOLUTIONS MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Nevada 3841 73-1526138 (State or other jurisdiction of incorporation) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identificatio

Revolutions Medical FORM 10-K (Annual Report)

rmcp2013123110k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ?ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended: December 31, 2013 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THESECURITIES EXCHANGE ACT OF 1934 REVOLUTIONS MEDICAL CORPORATION (Exact name of registrant as specified in

- FORM NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response ... 2.50 FORM 12b-25 SEC FILE NUMBER 000-28629 NOTIFICATION OF LATE FILING CUSIP NUMBER (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2013 ☐ Transition R

- FORM RW

rmcp20131119rw.htm revolutions medical corporation 670 MARINA DRIVE, 3rd FLOOR CHARLESTON, SC 29492 November 19, 2013 U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Revolutions Medical Corporation Registration Statement on Form S-1 Originally Filed February 14, 2012 File No. 333-179523 Ladies and Gentlemen: Pursuant to Rule 477

- FORM NT 10-Q

rmcp20131113nt10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-28629 (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: September 30, 2013 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Tra

Other Events - FORM 8-K

rmcp201310148k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 14, 2013 REVOLUTIONS MEDICAL CORPORATION. (Exact name of registrant as specified in its charter) Nevada 000-28629 73-1526138 (State or other jurisdiction of

- FORM NT 10-Q

rmcp20130813nt10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response ... 2.50 FORM 12b-25 SEC FILE NUMBER 000-28629 NOTIFICATION OF LATE FILING CUSIP NUMBER (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: June 30, 2

- FORM S-1/A

rmcps1a-010412.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A (Amendment No. 3) REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 REVOLUTIONS MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Nevada 3841 73-1526138 (State or other jurisdiction of incorporation) (Primary Standard Industrial Classification Code Number) (I.R.S. Em

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

rmcp201306208k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 17, 2013 REVOLUTIONS MEDICAL CORPORATION. (Exact name of registrant as specified in its charter) Nevada 000-28629 73-1526138 (State or other jurisdiction of in

June 15, 2013

rmcp201306208kex99-1.htm Exhibit 99.1 June 15, 2013 Ron Wheet, CEO Revolutions Medical Corporation 670 Marina Drive, 3rd Floor Charleston, SC 29492 Ron, I regret to inform you that I am resigning my position as Chief Financial Officer of Revolutions Medical Corporation effective immediately. I appreciate the opportunity that I have had to work for the Company. Sincerely, /s/ Burt Hodges Burt Hodge

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits - FORM 8-K

rmcp201306178k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 11, 2013 REVOLUTIONS MEDICAL CORPORATION. (Exact name of registrant as specified in its charter) Nevada 000-28629 73-1526138 (State or other jurisdiction of in

REGISTRATION RIGHTS AGREEMENT

rmcp201306178kex10-2.htm Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (the “Agreement”), dated as of June 10, 2013 (the “Execution Date”), is entered into by and Revolutions Medical Corporation, a Nevada corporation with its principal executive office at 670 Marina Drive, Third Floor, Charleston, SC 29492 (the “Company”), and KVM Capital Partners, a New York compan

INVESTMENT AGREEMENT

rmcp201306178kex10-1.htm Exhibit 10.1 INVESTMENT AGREEMENT This INVESTMENT AGREEMENT (the “Agreement”), dated as of June 10, 2013 (the “Execution Date”), is entered into by and between Revolutions Medical Corporation a Nevada corporation with its principal executive office at Revolutions Medical Corporation 670 Marina Drive, Charleston, SC 29492 (the “Company”), and KVM Capital Partners, a New Yor

- FORM NT 10-Q

rmcp20130515nt10q.htm OMB APPROVAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response ... 2.50 FORM 12b-25 SEC FILE NUMBER 000-28629 NOTIFICATION OF LATE FILING CUSIP NUMBER (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ende

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 26, 2013 REVOLUTIONS MEDICAL CORPORATION. (Exact name of registrant as specified in its charter) Nevada 000-28629 73-1526138 (State or other jurisdiction of incorporation) (Comm

Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review - FORM 8-K

rmcp201304308k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 29, 2013 REVOLUTIONS MEDICAL CORPORATION. (Exact name of registrant as specified in its charter) Nevada 000-28629 73-1526138 (State or other jurisdiction of i

Financial Statements and Exhibits, Other Events - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 16, 2013 REVOLUTIONS MEDICAL CORPORATION. (Exact name of registrant as specified in its charter) Nevada 000-28629 73-1526138 (State or other jurisdiction of incorporation) (Comm

- REQUEST FOR EXTENSION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-28629 CUSIP NUMBER 76154Q106 (Check one): ý Form 10-K o Form 20-F o Form 11-K Form 10-Q Form 10-D o Form N-SAR o Form N-CSR For Period Ended: December 31,

March 20, 2013

rmcp201303258kex99-1.htm Exhibit 16.1 March 20, 2013 Revolutions Medical, Inc. 670 Marina Drive, 3rd Floor Charleston, SC 29492 We have received a copy of, and are in agreement with, the statements being made by Revolutions Medical, Inc. in Item 4.01 of its Form 8-K dated March 20, 2013, captioned “Changes in Registrant’s Certifying Accountant”, We hereby consent to the filling of this letter as a

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

8-K 1 rmcp201303258k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 20, 2013 REVOLUTIONS MEDICAL CORPORATION. (Exact name of registrant as specified in its charter) Nevada 000-28629 73-1526138 (State or other ju

- FORM S-1/A2

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A (Amendment No. 2) REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 REVOLUTIONS MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Nevada 3841 73-1526138 (State or other jurisdiction of incorporation) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identificati

INTERNATIONAL MANUFACTURING AGREEMENT

Exhibit 10.14 INTERNATIONAL MANUFACTURING AGREEMENT This International Manufacturing Agreement ("this Agreement") entered into as of 1 December 2011 ("the Effective Date") between Revolutions Medical Corporation, a corporation organized and existing under the laws of the State of Nevada, United States of America, that has its principal place of business at 678 Marina Drive, 3rd Floor, Charleston,

Other Events - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 21, 2012 REVOLUTIONS MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Nevada 000-28629 73-1526138 (State or other jurisdiction of incorporation) (C

- FORM NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION OMB APPROVAL Washington, D.C. 20549 OMB Number: 3235-0058 Expires: August 31, 2012 FORM 12b-25 Estimated average burden hours per response ... 2.50 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-28629 CUSIP NUMBER (Check one): ¨ Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: June 30, 2012 ¨ Tra

- FORM S-1/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A (Amendment No. 1) REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 REVOLUTIONS MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Nevada 3841 73-1526138 (State or other jurisdiction of incorporation) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identificati

PROSPECTUS REVOLUTIONS MEDICAL CORPORATION 4,065,000 SHARES OF COMMON STOCK

Filed Pursuant to Rule 424(b)(3) Registration No. 333-167039 PROSPECTUS REVOLUTIONS MEDICAL CORPORATION 4,065,000 SHARES OF COMMON STOCK This prospectus relates to the resale of up to 4,065,000 shares of our common stock, par value $0.001 per share, by the selling security holders (the “Selling Security Holders”), including (i) 2,185,600 shares we issued to certain accredited investors in a privat

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant -

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 10, 2012 REVOLUTIONS MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Nevada 000-28629 73-1526138 (State or other jurisdiction of incorporation) (Co

FORM OF CONVERTIBLE PROMISSORY NOTE

NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS DOCUMENT NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.

REVOLUTIONS MEDICAL CORPORATION FORM OF COMMON STOCK PURCHASE WARRANT

NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS DOCUMENT NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.

FORM OF SUBSCRIPTION AGREEMENT

FORM OF SUBSCRIPTION AGREEMENT THIS SUBSCRIPTION AGREEMENT (this “Agreement”), dated as of , 2012, by and between Revolutions Medical Corporation, a corporation incorporated under the laws of the State of Nevada and located at 670 Marina Drive, 3rd Floor, Charleston, South Carolina 29292 (the “Company”), and , an individual located at (the “Subscriber”).

REGISTRATION RIGHTS AGREEMENT

REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is made and entered into as of the 29th day of December, 2011 by and between REVOLUTIONS MEDICAL CORPORATION, a Nevada corporation (the “Company”) and TCA GLOBAL CREDIT MASTER FUND, LP, a Cayman Islands limited partnership (the “Investor”).

Registration Statement - S-1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 REVOLUTIONS MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Nevada 3841 73-1526138 (State or other jurisdiction of incorporation) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 670 Marin

COMMITTED EQUITY FACILITY AGREEMENT

COMMITTED EQUITY FACILITY AGREEMENT This Committed Equity Facility Agreement (the “Agreement”) is dated as of the 29th day of December, 2011 the (“Effective Date”) by and between TCA GLOBAL CREDIT MASTER FUND, LP, a Cayman Islands limited partnership (the “Investor”) and REVOLUTIONS MEDICAL CORPORATION, a Nevada corporation (the “Company”).

-

REVOLUTIONS MEDICAL CORPORATION 670 MARINA DRIVE, 3RD FLOOR CHARLESTON, SC 29492 February 8, 2012 U.

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities

8-K 1 v2448438k.htm 8-K CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 29, 2011 REVOLUTIONS MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Nevada 000-28629 73-1526138 (State or o

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant - 8-K CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 29, 2011 REVOLUTIONS MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Nevada 000-28629 73-1526138 (State or other jurisdiction of incorporation) (Co

-

REVOLUTIONS MEDICAL CORPORATION 670 MARINA DRIVE, 3RD FLOOR CHARLESTON, SC 29492 November 16, 2011 Jay Mumford Division of Corporation Finance U.

REVOLUTIONS MEDICAL CORPORATION 670 MARINA DRIVE, 3RD FLOOR CHARLESTON. SC 29492

REVOLUTIONS MEDICAL CORPORATION 670 MARINA DRIVE, 3RD FLOOR CHARLESTON. SC 29492 October 7, 2011 Kevin L. Vaughn Accounting Branch Chief U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Revolutions Medical Corporation Form 10-K for the year ended December 31, 2010 Filed March 31, 2011 Form 10-Q for the quarter ended June 30, 2011

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 21, 2011 REVOLUTIONS MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Nevada 000-28629 73-1526138 (State or other jurisdiction of incorporation) (C

Thomas O’Brien

Thomas O’Brien 108 Dayton St. Danvers, MA 01923 September 20, 2011 Rondald Wheet Chairman & Chief Executive Officer Revolutions Medial Corp. 670 Marina Drive, 3rd Floor Charleston, South Carolina, 29492 Dear Ron, It is with deep regret that I must inform you that I am resigning my appointed positions as President and Director of Revolutions Medical Corporation, effective immediately, in accordance

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 REVOLUTIONS MEDICAL CORPORATION (Exact name of registrant as specified in its c

As filed with the U.S. Securities and Exchange Commission on September 23, 2011 Registration No. 333-167039 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 REVOLUTIONS MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Nevada 3841 73-1526138 (State or o

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A AMENDMENT NO. 2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 REVOLUTIONS MEDICAL CORPORATION (Exact name of registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A AMENDMENT NO. 2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 REVOLUTIONS MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Nevada 3841 73-1526138 (State or other jurisdiction of Incorporation) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended: March 31, 2011 ¨ TRANSITION REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended: March 31, 2011 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 000-28629 REVOLUTI

2007 STOCK OPTION PLAN REVOLUTIONS MEDICAL CORPORATION AMENDED AND RESTATED EFFECTIVE AS OF AUGUST 10, 2011

2007 STOCK OPTION PLAN OF REVOLUTIONS MEDICAL CORPORATION AMENDED AND RESTATED EFFECTIVE AS OF AUGUST 10, 2011 1.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2010 ¨ TRANSITION REPO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2010 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THESECURITIES EXCHANGE ACT OF 1934 REVOLUTIONS MEDICAL CORPORATION (Exact name of registrant as specified in

Revolutions Medical Corporation 670 Marina Drive, 3rd Floor Charleston, SC 29492

Revolutions Medical Corporation 670 Marina Drive, 3rd Floor Charleston, SC 29492 September 16, 2011 Kevin L.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 2) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended: June 30, 2011 ¨ TRANSITION REPORT P

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 2) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended: June 30, 2011 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 000-28629 REVOLUTIO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 6, 2011

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 6, 2011 REVOLUTIONS MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Nevada 000-28629 73-1526138 (State or other jurisdiction of incorporation) (Co

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended: June 30, 2011 ¨ TRANSITION REPORT P

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended: June 30, 2011 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 000-28629 REVOLUTIO

2007 STOCK OPTION PLAN REVOLUTIONS MEDICAL CORPORATION AMENDED AND RESTATED EFFECTIVE AS OF AUGUST 10, 2011

2007 STOCK OPTION PLAN OF REVOLUTIONS MEDICAL CORPORATION AMENDED AND RESTATED EFFECTIVE AS OF AUGUST 10, 2011 1.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended: June 30, 2011 ¨ TRANSITION REPORT PURSUANT TO SECTION 1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended: June 30, 2011 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 000-28629 REVOLUTIONS MEDICAL CORPORATI

REVOLUTIONS MEDICAL CORPORATION. 670 MARINA DRIVE, 3RD FLOOR CHARLESTON, SC 29492

REVOLUTIONS MEDICAL CORPORATION. 670 MARINA DRIVE, 3RD FLOOR CHARLESTON, SC 29492 August 2, 2011 Kevin L. Vaughn Division of Corporation Finance U.S. Securities & Exchange Commission 100 F Street, N E Washington, D.C. 20549 Re: Revolutions Medical Corporation Form 10-K for the year ended December 31, 2010 Filed March 31, 2011 Form 10-Q for the quarter ended March 31, 2011 Filed May 17, 2011 File N

Revolutions Medical Corporation 670 Marina Drive, 3rd Floor Charleston, SC 29492

Revolutions Medical Corporation 670 Marina Drive, 3rd Floor Charleston, SC 29492 June 24, 2011 Eric Atallah U.

REVOLUTIONS MEDICAL HIRES CHIEF FINANCIAL OFFICER

REVOLUTIONS MEDICAL HIRES CHIEF FINANCIAL OFFICER CHARLESTON, S.C., June 2, 2011 (GLOBE NEWSWIRE) – Revolutions Medical Corporation (“Revolutions Medical” or the “Company”) (OTCQB:RMCP) announces today that Burt Hodges has been named the Company’s new Chief Financial Officer. Mr. Hodges will immediately take over all management oversight responsibilities for financial functions and capital resourc

EMPLOYMENT AGREEMENT

EMPLOYMENT AGREEMENT AGREEMENT made as of June 6, 2011 between Revolutions Medical Corporation, a Nevada corporation with offices at 670 Marina Drive, 3rd floor, Charleston, SC 29492 (hereinafter called the “Company”), and Burt Hodges, residing at 206 Ferry St, Mt.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2011

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2011 REVOLUTIONS MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Nevada 000-28629 73-1526138 (State or other jurisdiction of incorporation) (Commiss

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A AMENDMENT NO. 1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 REVOLUTIONS MEDICAL CORPORATION (Exact name of registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A AMENDMENT NO. 1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 REVOLUTIONS MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Nevada 3841 73-1526138 (State or other jurisdiction of Incorporation) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification

Revolutions Medical Corporation 670 Marina Drive, 3rd Floor Charleston, SC 29492

Revolutions Medical Corporation 670 Marina Drive, 3rd Floor Charleston, SC 29492 May 31, 2011 Amanda Ravitz U.